baber/WOPTO huggingface dataset:
Patent EP-0479918-A4 (EP)
IPC: G01N25/72
Filed: 1990-07-20
Abstract: Système d'imagerie photoinductive servant à la détection de défauts de matériaux et à étalonner des sondes de courant parasite. Ce système comprend notamment la mise en place de la sonde de courant parasite (14) à proximité d'une éprouvette (12) devant être analysée ou devant être utilisée comme dispositif d'étalonnage. Une source d'énergie thermique (20) est modulée et focalisée sur une région ponctuelle de l'éprouvette. On balaie ensuite au moins une partie de la région de détection de la sonde de courant parasite (14) à l'aide d'une source d'énergie thermique. Le signal provenant de la sonde de courant parasite (14) est enregistré; il peut décrire soit les composants thermo-influencés de l'éprouvette (12) soit la configuration de réaction de la sonde de courant parasite (14). L'enregistrement peut par conséquent être utilisé pour représenter par une image les défauts, les trous ou les formes physiques de l'éprouvette ou pour étalonner la sonde de courant parasite (14).
Patent EP-0443036-A4 (EP)
Title: Method of determining kinetics of immunity
IPC: G01N33/50
Filed: 1990-09-07
Abstract: A method of determining and evaluating the kinetics of cell-mediated immunity, particularly that of cancer immunity by counting the number of CD3 positive lymphocytes, CD4 positive lymphocytes, CD8 positive lymphocytes, OKIal positive lymphocytes, NK cells, helper T lymphocytes, suppression inducer T lymphocytes, cytotoxic T lymphocytes, suppressor T lymphocytes, activated suppression inducer/helper T lymphocytes, activated suppressor/cytotoxic T lymphocytes, monocytes, basocytes, acidocytes and neutrocytes, and analyzing the results by multiple regression analysis as one technique of multivariate analysis.
Patent EP-0496749-A4 (EP)
Title: Spectrally resolvable rhodamine dyes for nucleic acid sequence determination
IPC: C09B69/10
Filed: 1990-09-27
Abstract: A spectrally resolvable set of rhodamine dyes are provided for use in the chain termination method of nucleic acid sequencing. A different rhodamine dye from the group consisting of tetramethylrhodamine, rhodamine X, rhodamine 6G, and rhodamine 110 is attached to the base of each of the dideoxynucleotides used in the sequencing method by way of an alkynylamino linker. Preferably, the labeled dideoxynucleotides are incorporated into the growing DNA chains by Taq DNA polymerase.
Patent EP-0485531-A4 (EP)
Title: Crosslinked polymer electrolyte and methods of making the same
IPC: H01G9/022
Filed: 1990-11-05
Abstract: Compact leak-proof electrolytic capacitors including, between the anode and the cathode, a layer of a solid polymer electrolyte, are disclsoed. The solid polymer electrolyte comprises (a) a solid solution of at least one salt selected from the group consisting of (i) alkali metal salts, (ii) alkaline earth metal salts, (iii) transition metal salts, (iv) ammonium salts, (v) organic ammonium salts and (vi) thallium salts of at least one acid selected from the group consisting of monobasic, dibasic and tribasic acids other than haloid acids in a polymer, and (b) a crosslinking agent selected from the group consisting of di-, tri- or polyisocyanates, di- and multifunctional acids, di- and multifunctional amines and di- and multifunctional unsaturated compounds which crosslink the polymer. Methods of making such capacitors are also disclosed. Rolled solid electrolyte capacitors of this type are characterized by low volume, absence of electrolyte leakage, and minimum dielecric deformation, and are capable of delivering intense bursts of current on demand, thereby being suitable for use in biomedical electronic devices such as cardiac pacemakers and defibrillators implanted in the human body.
Patent EP-0451293-A4 (EP)
Title: Production method for optical fiber base material
IPC: C03B37/018
Filed: 1990-10-31
Abstract: In accordance with a first method of the present invention, doping is conducted by forming two constricted portions (28) in a quartz reaction tube (4) and charging a solution containing a rare earth element compound as a solute between the constricted portions (28). Accordingly, a dope concentration becomes uniform in a longitudinal direction of an optical fiber base material (30) and moreover, defects are difficult to occur. Furthermore, complicated works are not necessary. In accordance with a second method of the present invention, a soot-like core glass (26) is impregnated with mist-like solution and high-precision control of a dope concentration becomes possible. In accordance with a third embodiment ot the present invention, the concentration is controlled in accordance with quantity of a laser beam passing through the soot-like core glass (26) and impregnation of the solution is carried out. In this manner a dope concentration not depending on the density of the soot-like core glass can be obtained. In accordance with a fourth method of the present invention, shaping of the soot-like core glass (26) is repeated several times at different temperatures, so that a dope concentration distribution in a core diameter direction can be set arbitrarily.
Patent EP-0456835-A4 (EP)
IPC: A61K31/517
Filed: 1990-12-10
Abstract: Dérivé de l'acide quinazoline-3-alcanoïque correspondant à la formule générale (I), présentant une activité inhibant aussi bien l'agglutination des plaquettes que l'aldose réductase, sels dérivés de ce composé, procédé de production de ce composé et médicament le contenant. Dans la formule, R représente hydrogène ou un groupe de protection du groupe carboxyle; R' représente alkyle inférieur, alcényle, alkynyle, alcoxy inférieur, alkylthio inférieur, halogène, phényle (qui peut être substitué par 1 à 3 substituants sélectionnés parmi des groupes alkyle inférieur, alcoxy inférieur, halogène, trifluorométhyle, carboxyéthylène et éthoxy-carbonyléthylène), naphtyle, hétérocycle (qui peut être substitué par 1 à 3 groupes alkyle inférieur), cycloalkyle, ou benzoyle (qui peut être substitué par alkyle inférieur ou halogène); R2 etR3 peuvent être identiques ou différents et représentent chacun hydrogène, halogène, alkyle inférieur, alcoxy inférieur, aralkyle éventuellement substitué, nitro, imidazolyle, imidazométhyle, ou -NR?4R5 où R4 et R5¿ peuvent être identiques ou différents et représentent chacun hydrogène ou alkyle inférieur, ou sont combinés entre eux pour former un hétérocycle à 5 ou 6 éléments pouvant contenir un ou plusieurs autres hétéroatomes; X représente carbonyle, thiocarbonyle ou méthylène (qui peut être substitué par alkyle inférieur); A représente alkylène inférieur ou alcénylène; et n est un entier compris entre 1 et 3.
Patent EP-0556284-A4 (EP)
IPC: A61B18/14
Filed: 1991-11-04
Abstract: A radiofrequency energy source (12) supplies electromagnetic energy to the applicator (14) which acts as an electrode. A control circuit (26) contains a comparator (42) which is connected to a temperature sensor (20) and a temperature reference device (44) for comparing the actual tissue temperature level with a desired temperautre level and provides control signals to the energy source (12) for controlling the output to the applicator. A second electrode (96) provides a current return for the heating current from applicator (14). A sheet or sheath of insulation material covers the applicator (14) insulating it from the tissue; the thickness of the sheet or sheath may be varied to provide uniform tissue heating along the length of the applicator.
Patent EP-0641368-A4 (EP)
Inventor: ALVAREZ EDUARDO
IPC: C08L77/00
Filed: 1993-03-11
Abstract: L'invention se rapporte à une composition moulable par injection contenant un polymère aromatique ainsi qu'un groupe hétérocyclique, un polymère au moins partiellement aromatique, traitable par fusion et de faible viscosité, sélectionné parmi le groupe constitué par des polyéthers, des polycétones, des polyéthercétones, des cétones de polyéther-éther, des polyamides et des polyesters, ainsi qu'un agent de renforcement. L'agent de renforcement est de la fibre de verre, de la fibre de carbone ou une combinaison de celles-ci.
Patent EP-0642720-A4 (EP)
Title: Data communication receiver having burst error protected data synchronization.
Inventor: WILLARD DAVID FRANK
IPC: H04J3/06
Filed: 1993-05-20
Abstract: A data communication receiver (106) providing burst error protected data synchronization comprises a receiver portion (804) for receiving and detecting synchronization data and message information. The synchronization data comprises at least first and second synchronization code words separated by a predetermined transmission time interval. A synchronization correlator (818, 1310 or 1330) correlates for the first synchronization code word, and in the absence of correlating the first synchronization code word, correlates for the second synchronization code word, thereby insuring synchronization with the received message information.
Patent EP-0648313-A4 (EP)
Inventor: BELL RONALD D
IPC: B01D53/86
Filed: 1993-06-24
Abstract: L'invention se rapporte à un processus et un système de cogénération de NOx réduit pour produire de l'électricité et une puissance calorifique. On fournit du combustible et de l'oxygène à un moteur à combustion interne (10) connecté pour entraîner un générateur électrique (9) et produire ainsi de l'électricité. Un courant d'échappement est récupéré à partir du moteur. On ajoute le combustible au courant d'échappement pour créer un mélange riche en combustible. Le courant enrichi en combustible est amené à une chambre de post-combustion (18) pour obtenir un courant calorifique appauvri en oxygène. Le courant appauvri en oxygène est refroidi dans un premier échangeur de chaleur (22). L'oxygène de conversion est mélangé avec le courant refroidi qui est ensuite passé sur un lit catalytique (25) dans des conditions de réduction totale. On refroidit le courant provenant du lit catalytique réducteur et on ajoute de l'air pour obtenir un autre courant refroidi que l'on fait ensuite passer sur un lit catalytique oxydant (26) pour oxyder les combustibles restants.
Patent EP-0705314-A4 (EP)
Inventor: MOWREY DOUGLAS H
IPC: C09J123/28
Filed: 1993-09-28
Abstract: On a découvert une composition adhésive qui offre une forte liaison caoutchouc-métal et une excellente résistance à l'environnement sans exiger au préalable le dépôt d'une couche de fond sur la surface métallique. Cette composition comprend une polyoléfine contenant un halogène, un composé nitroso aromatique, un composé polymaléimide et un oxyde métallique tel qu'un oxyde de zinc ou de magnésium. Cette composition peut, à titre facultatif, contenir un agent de vulcanisation tel que le soufre ou le sélénium, une résine époxy phénolique ou du noir de carbone.
Patent EP-0693927-A4 (EP)
Title: Method for treatment of menopausal and premenstrual symptoms
Inventor: GORBACH SHERWOOD L
IPC: A23L1/30
Filed: 1994-04-15
Abstract: A method is provided for preventing or treating symptoms of menopause, premenstrual syndrome, or a condition resulting from reduced levels of endogenous estrogen, by administering to the woman an effective amount of an isoflavonoid. The invention also features a therapeutic dietary product, containing isoflavonoids, for preventing or treating symptoms of conditions resulting from reduced or altered levels of endogenous estrogen.
Patent EP-0662604-A4 (EP)
Title: Method and apparatus for measuring dynamic load.
Inventor: TADA EIICHI
IPC: G01G23/10
Filed: 1994-05-16
Abstract: A method and apparatus for measuring a dynamic load without being influenced by vibrations caused by the apparatus itself and the environment. A DLS (the main body of a dynamic load sensor) (10) is periodically vibrated by the reciprocation of a slide base (4) and the vertical movement of a base plate (9). In the DLS (10), one end of a member constituting a spring system is fixed to the base of a non-spring system; the other end is free. A load is applied to the free end of the member constituting the spring system. The base is periodically vibrated continuously together with the member constituting the spring system. The displacement y1 of the base, and the displacement y2 of the free end are continously measured. By using the first derivatives y1 and y2 and the second derivatives ij1 and ij2 of the displacements y1 and y2, the mass m of the load is calculated by the following equation: m[ij]=mg-[(mg+kf2(y-y1+y2))-f3(y-y1+y2)+f1(mij1,mij2)] (where the symbol [] represents a determinant having terms the number of which is equal to the product of the number of degrees of freedom by the number of data, g is the acceleration of gravity, kf2(y-y1+y2) is the material constant of the member constituting the spring system, k is a constant of proportionality, f3(y-y1+y2) is an attenuation term expressing the attenuation such as by viscosity, friction, hysteresis, fluid resistance, or transient state added resistance, and f1(mij1,mij2) is the vibromotive force).
Patent EP-0703768-A4 (EP)
Title: Anatomically conformable therapeutic mattress overlay
Inventor: FARLEY DAVID L
IPC: A61G7/05
Filed: 1994-06-02
Abstract: A therapeutic mattress overlay for supporting a recumbent human body so as to redistribute body weight away from prominent areas of the human body and also to support selected anatomical body portions, e.g., the lower extremities, of the recumbent human body has a substantially planer resilient member having top and bottom surfaces and first and second edges. Reinforcements extend from proximate the first edge to proximate the second edge of the planer resilient mender such that a patient may be rotated by grasping the reinforcements proximate the first edge of the resilient member and lifting the first edge thereof so as to cause the patient to roll toward the second edge thereof. The reinforcements prevent damage to the resilient member during lifting of the first edge. The pad is formed to have at least one area of less resistance thereon which corresponds to protruding portion(s) of a human body.
Patent EP-0712399-A4 (EP)
IPC: C07C67/54
Filed: 1994-08-01
Abstract: Starting from a mixture containing tocopherol, fats and/or fat derivatives, more particularly fatty acids, and optionally sterol and/or sterol derivatives, the free fatty acids present in the mixture are esterified with an alcohol. The mixture is then transesterified with an alcohol in the presence of a basic catalyst. After the transesterification, the excess lower alcohol is distilled off from the reaction mixture. The transesterification catalyst and the glycerol present, if any, are removed and the fatty acid alkyl ester is distilled off from the mixture. Distillation of fatty acid alkyl esters can be accomplished with a packed column in sequence with a wiped film evaporator. The simultaneous recovery of tocopherol and sterol is possible. Tocopherols and sterols can be separated by the crystallization of sterols from a blend of organic solvents.
Patent EP-0755685-A4 (EP)
Title: Medicinal composition for treating tardive dyskinesia and utilization thereof
Inventor: MAEDA YOHKO
IPC: C07D207/26
Filed: 1995-04-14
Abstract: A medicinal composition for treating tardive dyskinesia, which contains a compound having a phosphodiesterase inhibitory activity as the active ingredient, a preferable example thereof being rolipram. When this compound is administered to an experimental model of tardive dyskinesia induced by the chronic administration of haloperidol to rats, it exhibits a therapeutic effect of suppressing the symptom of tardive dyskinesia in a dose-dependent manner.
Patent EP-0821004-A4 (EP)
Title: Novel peptides and remedy for bone diseases containing the same as active ingredient
Inventor: SAKAMOTO KENJI
IPC: C07K7/08
Filed: 1996-04-03
Abstract: A new substance useful as a drug for the treatment of osteopathy is disclosed. The present invention provides a peptide and derivative thereof, said peptide having an amino acid sequence designated hereunder as follows, wherein both of the peptide and derivative thereof having growth promotion effects and activity promotion effects on osteoblasts, as well as a drug having the peptide as an effective component for the treatment of osteopathy. <IMAGE>
Patent EP-0890293-A4 (EP)
Inventor: BOYDEN JAMES H
IPC: H04R1/00
Filed: 1996-05-21
Abstract: Cette invention concerne un système (50) de communication personnel et de divertissement pouvant être porté sur soi, lequel système offre un son d'une grande qualité, notamment à des fréquences audio basses, et n'arrête ni n'atténue les sons du milieu environnant. Dans un premier mode de réalisation, un transducteur ou un ensemble de transducteurs (55) est disposé sur une paroi dans une chambre d'échantillonnage, entre deux cavités (54). L'une des cavités est hermétique tandis que l'autre possède un ou plusieurs éléments de conduit qui dirigent les signaux acoustiques vers une ou vers les deux oreilles de la personne portant ce système sur elle. Dans un second mode de réalisation, les deux cavités possèdent des conduits qui sont chacun dirigés vers chacune des oreilles de la personne portant le système sur elle. Dans l'un ou l'autre mode de réalisation, la chambre d'échantillonnage peut éventuellement être combinée à des transducteurs à haute fréquence séparés. Dans les deux modes de réalisation, les chambres sont incorporées dans un accessoire vestimentaire tandis que les transducteurs sont connectés à une source de signaux audio.
Patent EP-0902723-A4 (EP)
Title: Immersible rotary disc filtration device
Inventor: ROLCHIGO PHILIP M
IPC: B01D65/08
Filed: 1996-11-22
Abstract: Rotary disc filtration devices and filtration processes using those devices are disclosed. The devices have one or more fluid filtration gaps into which fluid to be filtered into permeate and retentate is placed. Each fluid filtration gap is defined by a disc and a filter, one of which rotates with respect to the other. The filter is carried on a filter member. The discs and interleaved filter members may be suspended from the top of the device, the top may rest on a vessel containing the fluid to be filtered, the discs may be attached to a single shaft for rotation, and the filter members may be suspended from a sleeve around the shaft, which sleeve keeps the filters centered with respect to the discs. Removal of the device's top removes the discs and filter members together, facilitating maintenance. Each filter member may have a peripheral lip and the lips of adjacent filter members may be sufficiently close to one another to substantially restrict the flow of retentate out of the fluid filtration gap. Retentate flowing out of each fluid filtration gap may be directed into the vessel to counteract the tendency of the fluid in the vessel to rotate in the same direction as the discs are rotated, or the retentate may be recycled directly to the fluid filtration gaps. The liquid level in the vessel may be held constant using a dual-pipe system and three-head peristaltic pump.
Patent EP-0946248-A4 (EP)
Title: Filter with counter flow clearing
Inventor: OBST YURI
IPC: B01D29/96
Filed: 1997-12-01
Abstract: A filter system (10) comprising a filter medium (11) for filtering contaminants from a process fluid, having a filtration side on which contaminants collect and a filtrate side from which filtrate flows; a counter-flow generator (20) located on the filtrate side that directs a localized stream of counter-flow fluid (23) from the filtrate side to the filtration side of the filter medium (11) to thereby dislodge the contaminants from the filtration side of the filter medium (11), wherein the localized stream (23) traverses a substantial proportion of the filter medium (11). The filter system (10) optionally further comprises a clearing-flow generator (30) or like means located on the filtration side of the filter medium (11) which clears contaminants from the filter medium (11).
Patent EP-0892000-A4 (EP)
Title: Ethylene terephthalate/ethylene 2,6-naphthalene-dicarboxylate copolymers for bottles
Inventor: UMEDA MASAMI
IPC: C08G63/189
Filed: 1997-04-01
Abstract: Ethylene terephthalate/ethylene 2,6-naphthalene-dicarboxylate copolymers wherein 2,6-naphthalene-dicarboxylic acid is copolymerized in an amount of 5 to 20 mole % based on the whole dicarboxylic acid component. These copolymers are controlled in the content of Mn, Mg and Co resulting from catalysts or the like and that of P resulting from phosphorus compounds used as stabilizers and therefore are excellent in hue (i.e., colorless) and have a high transparency, thus being useful as a molding material for bottles.
Patent EP-0960020-A4 (EP)
Title: In-mold labels and uses thereof
Inventor: BALAJI RAMABHADRAN
IPC: C08L23/14
Filed: 1998-01-09
Abstract: This invention relates to an in-mold label comprising a core layer with a first and second surface and a heat seal layer on the first surface of the core layer, wherein the heat seal layer comprises a polyolefin, having a peak melt temperature of less than about 110 °C and where less than about 25 % of the polyolefin melts at a temperature of less than 50 °C as measured by differential scanning calorimetry. The label may also contain a skin layer on the second surface of the core layer. The invention also relates to plastic substrates bonded to the label. In another aspect, the present invention also relates to a process for in-mold labeling and a process for preparing an in-mold label. The labels and processes provide reduced amounts of one or more of the following: blisters, both before and after bonding, shrinkage, bagginess and gage bands.
Patent EP-1012331-A4 (EP)
Title: Compositions and methods for the delivery of oligonucleotides via the alimentary canal
Inventor: TENG CHING-LEOU
IPC: C07H21/04
Filed: 1998-07-01
Abstract: The present invention relates to compositions and methods which enhance the local and systemic uptake and delivery of oligonucleotides and nucleic acids via non-parenteral routes of administration. Pharmaceutical compositions comprising oligonucleotides disclosed herein include, for systemic delivery, emulsion and microemulsion formulations for a variety of applications and oral dosage formulations. It has also surprisingly been discovered that oligonucleotides may be locally delivered to colonic sites by rectal enemas and suppositories in simple solutions, e.g., neat or in saline. Such pharmaceutical compositions of oligonucleotides may further include one or more penetration enhancers for the transport of oligonucleotides and other nucleic acids across mucosal membranes. The compositions and methods of the invention are utilized to effect the oral, buccal, rectal or vaginal administration of an antisense oligonucleotide to an animal in order to modulate the expression of a gene in the animal for investigative, therapeutic, palliative or prophylactic purposes.
Patent EP-0961525-A4 (EP)
Inventor: YUDASAKA ICHIO
IPC: H05B33/26
Filed: 1998-08-25
Abstract: La présente invention concerne un affichage matriciel actif (1) dans lequel chaque pixel (7) comprend: un élément photoémetteur à couche mince (40) muni d'une électrode de pixel (41); une couche semiconductrice organique (43) formée sur l'électrode de pixel (41); et une électrode opposée (op) formée sur la couche semiconductrice organique (43). Une couche protectrice (60) est formée sur l'électrode opposée (op) de façon qu'elle recouvre presque la totalité de la surface du substrat. La couche protectrice (60) empêche le contact avec l'humidité ou l'oxygène et protège de la sorte l'élément photoémetteur à couche mince (40) contre les détériorations.